Arena Pharmaceuticals (ARNA) Stock Analysis

What Arena Pharmaceuticals does

Arena Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing innovative therapeutic agents, specifically designed with distinct pharmacological and pharmacokinetic profiles, for a global patient population. Its extensive pipeline features several key investigational medicines. Etrasimod (APD334) is undergoing diverse clinical evaluations, including a Phase III study for ulcerative colitis, a Phase IIb/III trial for Crohn's disease, a Phase II trial for alopecia areata, a separate Phase III trial for atopic dermatitis, and a Phase IIb study for eosinophilic esophagitis. Olorinab (APD371) is currently in a Phase IIb clinical trial, targeting abdominal discomfort linked to irritable bowel syndrome. APD418 is progressing through Phase II trials for acute heart failure, while Temanogrel is also in Phase II development, addressing coronary microvascular obstruction. Furthermore, Ralinepag (APD811) is undergoing Phase III clinical assessment for pulmonary arterial hypertension. Arena maintains collaborative alliances with a range of entities, such as United Therapeutics Corporation, Everest Medicines Limited, Eisai Co., Ltd. and Eisai Inc., Boehringer Ingelheim International GmbH, Beacon Discovery, Inc., and Aristea Therapeutics, Inc. Established in 1997, Arena Pharmaceuticals, Inc. operates from its headquarters in Park City, Utah. As of March 11, 2022, the company functions as a subsidiary of Pfizer Inc.

Key metrics

ETFs linked to ARNA

Broad-market and Healthcare sector ETFs an investor holding Arena Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ARNA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Arena Pharmaceuticals?

Arena Pharmaceuticals trades under the ticker ARNA on NASDAQ.

Which exchange is ARNA listed on?

ARNA is listed on NASDAQ.

What sector does Arena Pharmaceuticals operate in?

Arena Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ARNA in a portfolio?

PortView shows ARNA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.